Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | IDO1 | P14902 | 4/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | CASP7 | P55210 | 1/20 | 0.39 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.38 |
| ▸ | GPR68 | Q15743 | 1/20 | 0.38 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.36 |
| ▸ | NPC1 | O15118 | 4/20 | 0.36 |
| ▸ | GAA | P10253 | 4/20 | 0.36 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29889875 | 1.00 | ALDH1A1 (0.52) | ALDH1A1L3MBTL1IDO1HSD17B10ACE2 | |
| SCHEMBL16731968 | 0.83 | ALDH1A1 (0.37) | ALDH1A1L3MBTL1IDO1HSD17B10BCHE | |
| SCHEMBL1317752 | 0.83 | ALDH1A1 (0.37) | ALDH1A1L3MBTL1IDO1HSD17B10ACE2 | |
| SCHEMBL1232419 | 0.81 | ALDH1A1 (0.57) | ALDH1A1L3MBTL1IDO1HSD17B10ACE2 | |
| SCHEMBL29521927 | 0.81 | ALDH1A1 (0.52) | ALDH1A1L3MBTL1IDO1HSD17B10HSP90AA1 | |
| SCHEMBL31158157 | 0.79 | CYP3A4 (0.48) | ALDH1A1L3MBTL1IDO1HSD17B10HSP90AA1 | |
| SCHEMBL8744274 | 0.77 | ALDH1A1 (0.46) | ALDH1A1L3MBTL1IDO1HSD17B10ACE2 | |
| SCHEMBL13860777 | 0.75 | ALDH1A1 (0.72) | ALDH1A1L3MBTL1IDO1HSD17B10ACE2 | |
| SCHEMBL29793563 | 0.75 | ALDH1A1 (0.63) | ALDH1A1L3MBTL1IDO1HSD17B10ACE2 | |
| SCHEMBL10995283 | 0.75 | ALDH1A1 (0.63) | ALDH1A1L3MBTL1IDO1HSD17B10ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117186481-A | Polyphenol hydroxyl COFs aerogel rich in hydrogen bond donor, and preparation method and application thereof | 中南大学 | 2023-12-08 | — | — | CN | claimed |
| CN-117143305-A | NH (NH) 2 -COFs@ZnS photocatalytic material and preparation method and application thereof | 中南大学 | 2023-12-01 | — | — | CN | claimed |
| CN-116925372-A | nanocarbon@COFs hybrid material with thienyl core-shell structure and preparation method and application thereof | 中南大学 | 2023-10-24 | — | — | CN | claimed |
| CN-114713286-B | Ti-MOFs@COFs hybrid material with stable core-shell structure and preparation method and application thereof | 中南大学 | 2023-06-20 | — | — | CN | claimed |
| CN-114713286-A | Ti-MOFs @ COFs hybrid material with stable core-shell structure and preparation method and application thereof | 中南大学 | 2022-07-08 | — | — | CN | claimed |
| US-20260103446-A1 | CFTR REGULATORS AND METHODS OF USE THEREOF | UNIV CALIFORNIA (US) | 2026-04-16 | — | — | US | disclosed |
| EP-4724059-A1 | USE OF CALCIUM SENSING RECEPTOR ANTAGONISTS FOR TREATING OCULAR DISORDERS | The Regents of University of California (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-4019501-B1 | CFTR REGULATORS AND METHODS OF USE THEREOF | UNIV CALIFORNIA (US) | 2026-02-04 | — | — | EP | disclosed |
| US-12503447-B2 | CFTR regulators and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-12-23 | — | — | US | disclosed |
| US-20250367207-A1 | OCULAR PHARMACEUTICAL COMPOSITIONS | UNIV CALIFORNIA (US) | 2025-12-04 | — | — | US | disclosed |
| US-12391654-B2 | CFTR regulators and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-08-19 | — | — | US | disclosed |
| US-20250109113-A1 | CFTR REGULATORS AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-04-03 | — | — | US | disclosed |
| WO-2017112947-A1 | CFTR REGULATORS AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-06-29 | — | — | WO | disclosed |
| WO-2017112951-A1 | CFTR REGULATORS AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-06-29 | — | — | WO | disclosed |
| WO-2017112950-A1 | CFTR REGULATORS AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-06-29 | — | — | WO | disclosed |
| CN-106159327-A | Lithium rechargeable battery | 凯思普科技有限责任公司 | 2016-11-23 | — | — | CN | disclosed |
| CN-102225918-A | 1,2,3-thiadiazole formyl urea compounds as well as preparation method and application thereof | LIER CHEMICAL CO LTD | 2011-10-26 | — | — | CN | disclosed |
| CN-102061180-A | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | CHISSO CORP | 2011-05-18 | — | — | CN | disclosed |
| EP-1377627-A2 | CONJUGATED HOMO- AND COPOLYMERS COMPRISING SUBSTITUTED OR UNSUBSTITUTED HETEROARYL GROUP, ITS PREPARATION AND USES | Cambridge Display Technology Limited (GB) | 2004-01-07 | — | — | EP | disclosed |
| WO-2002083760-A2 | CONJUGATED HOMO-AND COPOLYMERS COMPRISING SUBSTITUTED OR UNSUBSTITUTED HETEROARYL GROUP, ITS PREPARATION AND USES | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2002-10-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250367207-A1 | OCULAR PHARMACEUTICAL COMPOSITIONS | PLA2G2D, PLA2G2C, PLA2G3 | ALDH1A1 2594/4885L3MBTL1 4881/4885IDO1 189/4885 |
| US-12391654-B2 | CFTR regulators and methods of use thereof | CFTR, SLC26A4, CLCN2 | ALDH1A1 2135/4885L3MBTL1 4625/4885IDO1 3422/4885 |
| US-20260103446-A1 | CFTR REGULATORS AND METHODS OF USE THEREOF | CFTR, CLCN2, SLC26A3 | ALDH1A1 1179/4885L3MBTL1 4701/4885IDO1 3046/4885 |
| US-12503447-B2 | CFTR regulators and methods of use thereof | CFTR, SLC26A4, CLCN2 | ALDH1A1 2135/4885L3MBTL1 4625/4885IDO1 3422/4885 |
| US-20250109113-A1 | CFTR REGULATORS AND METHODS OF USE THEREOF | CFTR, SLC26A4, CLCN2 | ALDH1A1 2135/4885L3MBTL1 4625/4885IDO1 3422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.